Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Astagraf Xl
Generic Name
Tacrolimus Extended-release Capsules
Active Ingredient
TacrolimusCategory
Other
Variants
3
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Astagraf Xl, you must consult a qualified healthcare professional.
Detailed information about Astagraf Xl
Tacrolimus is a potent calcineurin inhibitor immunosuppressant used primarily to prevent organ rejection in transplant recipients and manage severe atopic dermatitis.
Dosage for tacrolimus is highly individualized and must be adjusted based on the patient's blood trough levels (the lowest concentration of the drug in the blood before the next dose).
Children often metabolize tacrolimus faster than adults and may require higher doses on a mg/kg basis to achieve the same therapeutic blood levels.
While tacrolimus is not cleared by the kidneys, it is nephrotoxic (toxic to the kidneys). In patients with pre-existing renal impairment or those experiencing a decline in kidney function, healthcare providers may delay the start of tacrolimus or use lower doses.
Since the liver is the primary site of tacrolimus metabolism, patients with severe hepatic impairment (liver failure) will clear the drug much more slowly. Significant dose reductions are often required to prevent toxic accumulation.
Clinical trials have not shown significant differences in response between elderly and younger patients. However, due to the higher frequency of decreased hepatic or renal function in the elderly, doctors typically start at the lower end of the dosing range.
If you miss a dose, take it as soon as you remember, provided it is within 2 hours of the scheduled time. If more than 2 hours have passed, skip the missed dose and take your next dose at the regular time. Never double the dose to make up for a missed one. Frequent missed doses significantly increase the risk of organ rejection.
Signs of an acute overdose may include tremors, headache, nausea, vomiting, and a rapid increase in blood creatinine (indicating kidney stress). If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately. There is no specific antidote for tacrolimus; treatment consists of supportive care and monitoring.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or switch between different brands or formulations of tacrolimus without medical guidance, as they are not all interchangeable.
Tacrolimus is a potent medication, and side effects are very common, especially in the first few months after a transplant when doses are highest.
Tacrolimus is a high-alert medication that requires strict adherence and frequent medical monitoring. It should only be prescribed by physicians experienced in immunosuppressive therapy and the management of organ transplant patients. Patients must be managed in facilities with adequate laboratory and supportive medical resources.
1. Increased Risk of Serious Infections: Because tacrolimus suppresses the immune system, patients are at a significantly higher risk for developing serious infections that may lead to hospitalization or death. These include 'opportunistic' infections that would not normally affect healthy individuals.
2. Increased Risk of Malignancy: Long-term immunosuppression with tacrolimus increases the risk of developing cancers, especially lymphoma and skin cancer. This risk appears related to the intensity and duration of immunosuppression.
Certain drugs should never be used with tacrolimus because they cause extreme changes in drug levels or toxicity:
Tacrolimus must NEVER be used in the following situations:
These are conditions where the risk of using tacrolimus may outweigh the benefit, or where extreme caution is required:
Tacrolimus is known to cross the placenta. According to data from the Transplant Pregnancy Registry International, tacrolimus use during pregnancy is associated with an increased risk of premature delivery (before 37 weeks) and low birth weight.
Tacrolimus is a macrolide immunosuppressant that exerts its effect primarily by inhibiting T-lymphocyte activation. The molecular process involves:
Common questions about Astagraf Xl
Tacrolimus is primarily used as an immunosuppressant to prevent the body from rejecting a transplanted organ, such as a kidney, liver, or heart. It works by quieting the immune system, specifically the T-cells that would otherwise attack the new organ as a foreign object. In addition to transplant medicine, a topical ointment form of tacrolimus is used to treat moderate-to-severe atopic dermatitis (eczema) in patients who cannot use or do not respond to steroid creams. Occasionally, doctors may use it off-label for other autoimmune conditions like Crohn's disease or certain types of nephrotic syndrome. It is a critical, life-saving medication for transplant recipients that must be taken for the lifetime of the organ.
The most common side effects of tacrolimus include tremors (shaking of the hands), headaches, and high blood pressure. Many patients also experience kidney dysfunction, which is monitored through regular blood tests for creatinine. Increased blood sugar levels are also frequent, and some patients may develop 'new-onset diabetes after transplant' (NODAT). Other common issues include gastrointestinal upset like diarrhea or nausea, and electrolyte imbalances such as high potassium or low magnesium. Because the drug suppresses the immune system, patients are also more susceptible to catching common infections like colds, the flu, or urinary tract infections.
Drinking alcohol while taking tacrolimus is generally discouraged and should only be done after consulting your transplant team. Alcohol can increase the risk of side effects like dizziness and confusion, and it may interfere with how your liver processes the medication. Specifically, with certain extended-release versions of tacrolimus (like Astagraf XL), alcohol can cause the medication to be released into your bloodstream too quickly, a dangerous phenomenon known as 'dose dumping.' Furthermore, chronic alcohol use can stress the liver and kidneys, which are already under pressure from the medication. If you do choose to drink, it should be in very limited quantities and never at the same time you take your dose.
Tacrolimus use during pregnancy involves significant risks and requires a detailed discussion with a high-risk obstetrician and a transplant specialist. While it is not strictly forbidden, it is associated with higher rates of premature birth and low birth weight in infants. Some babies born to mothers on tacrolimus may have temporary kidney issues or high potassium levels at birth. However, the risk of stopping the medication—which would lead to organ rejection—is usually considered much more dangerous for both the mother and the fetus. Most transplant patients can have successful pregnancies, but their tacrolimus doses will need frequent adjustment and very close monitoring.
Tacrolimus begins to affect the immune system shortly after the first dose, but it takes several days to reach a 'steady state' in the bloodstream. For transplant patients, the medication is usually started immediately before or after the surgery to provide instant protection against rejection. When used as a topical ointment for eczema, patients typically see an improvement in their skin symptoms within 1 to 2 weeks of starting treatment. Because the drug has a narrow therapeutic window, doctors will check blood levels frequently in the first few weeks to ensure the dose is high enough to be effective but low enough to avoid toxicity. It is not a medication that provides 'instant' relief but rather a continuous shield for the immune system.
No, you must never stop taking tacrolimus suddenly unless specifically instructed by your transplant surgeon. Stopping the medication will cause your immune system to immediately begin attacking your transplanted organ, which can lead to organ failure, the need for a new transplant, or death. Rejection can happen very quickly, sometimes within days of stopping the drug. If you are experiencing severe side effects, your doctor may adjust your dose or switch you to a different immunosuppressant, but this must be done under strict medical supervision. Consistency is the most important factor in the long-term survival of your transplant.
If you miss a dose of tacrolimus, you should take it as soon as you remember, but only if it is within 2 hours of your scheduled time. If more than 2 hours have passed since you were supposed to take your dose, skip the missed dose entirely and take your next dose at the regular time. You should never take two doses at once to make up for a missed one, as this could lead to toxic levels of the drug in your blood. It is helpful to use an alarm or a pill organizer to prevent missed doses. If you miss more than one dose in a row, contact your transplant coordinator immediately for guidance.
Tacrolimus itself does not typically cause significant weight gain in the same way that corticosteroids (like prednisone) do. However, many transplant patients take tacrolimus in combination with prednisone, which is well-known for causing increased appetite and weight gain. Additionally, as patients feel better after a successful transplant, their appetite often improves, leading to natural weight gain. Some patients may also experience fluid retention (edema) as a side effect of tacrolimus, which can show up as a higher number on the scale. If you notice rapid weight gain or swelling in your legs, you should contact your healthcare provider to check your kidney function and fluid balance.
Tacrolimus has a very high number of drug interactions, so it must be used cautiously with other medications. Many common drugs, including certain antibiotics, antifungals, and blood pressure medications, can significantly raise or lower the levels of tacrolimus in your blood. Even over-the-counter drugs like ibuprofen (Advil) or naproxen (Aleve) should be avoided because they can increase the risk of kidney damage when combined with tacrolimus. Herbal supplements like St. John's Wort are particularly dangerous. Always provide a full list of all medications, vitamins, and supplements to your transplant team before starting anything new.
Yes, tacrolimus is available as a generic medication in both its immediate-release capsule and topical ointment forms. Generic versions are generally much more affordable than brand-name versions like Prograf or Protopic. However, because tacrolimus is a 'narrow therapeutic index' drug, some transplant surgeons prefer that patients stay on the same manufacturer's version consistently. Switching between different generic manufacturers or between a brand and a generic can sometimes cause slight fluctuations in blood levels. If your pharmacy changes the manufacturer of your generic tacrolimus, you should inform your transplant team so they can monitor your blood levels more closely for a short period.
Other drugs with the same active ingredient (Tacrolimus)
> Warning: Stop taking Tacrolimus and call your doctor immediately if you experience any of these.
The FDA has issued several Black Box Warnings for tacrolimus:
Report any unusual symptoms or changes in your health to your healthcare provider immediately. Regular blood tests are mandatory to monitor for these side effects.
Tacrolimus can cause both acute and chronic kidney damage. Acute damage is often reversible by lowering the dose, but chronic damage can be permanent. Your doctor will monitor your serum creatinine and BUN (blood urea nitrogen) levels closely. Avoid other medications that can damage the kidneys, such as ibuprofen or naproxen, while taking tacrolimus.
Tacrolimus can affect the nervous system. Symptoms range from mild tremors and headaches to severe complications like seizures, coma, or Posterior Reversible Encephalopathy Syndrome (PRES). If you experience sudden changes in vision or mental status, seek emergency care.
Tacrolimus is known to increase blood sugar levels and can cause permanent diabetes in some transplant patients. This risk is higher in African American and Hispanic patients. Regular monitoring of fasting blood glucose and HbA1c is required.
Tacrolimus may prolong the QT interval (the time it takes for the heart's electrical system to reset). This can lead to a life-threatening heart rhythm called Torsades de Pointes. This risk is higher if you have low potassium or are taking other medications that affect heart rhythm.
To ensure safety and efficacy, you will need frequent blood tests, especially in the first few months after starting the drug:
Tacrolimus may cause visual or neurological disturbances, including tremors and dizziness. Do not drive or operate heavy machinery until you know how the medication affects you, especially when first starting the drug or after a dose increase.
Alcohol should be used with extreme caution. Alcohol can increase the risk of side effects and may interfere with the metabolism of the drug. Furthermore, some extended-release formulations (like Astagraf XL) can release the drug too quickly into the bloodstream if consumed with alcohol ('dose dumping').
Never stop taking tacrolimus suddenly. Doing so will almost certainly lead to organ rejection and could be fatal. If the drug must be discontinued, it must be done under the strict supervision of a transplant specialist, usually while transitioning to a different immunosuppressant.
> Important: Discuss all your medical conditions, including any history of heart, liver, or kidney disease, with your healthcare provider before starting Tacrolimus.
These drugs speed up the breakdown of tacrolimus, increasing the risk of organ rejection:
Tacrolimus does not typically interfere with the chemistry of lab tests, but it can significantly alter the results of tests such as fasting glucose (raising it) or serum potassium (raising it). Always inform any lab technician or specialist that you are on an immunosuppressant regimen.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter vitamins can sometimes affect how tacrolimus works in your body.
There is no documented cross-sensitivity between tacrolimus and other common drug classes (like penicillins or sulfonamides). However, patients who have had severe reactions to other calcineurin inhibitors, such as cyclosporine, should be monitored closely, as the side effect profiles (like kidney stress and high blood pressure) are very similar.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug allergies or underlying heart and liver conditions, before prescribing Tacrolimus.
Tacrolimus is approved for use in children following kidney, liver, or heart transplants.
Patients over the age of 65 may be more sensitive to the side effects of tacrolimus, particularly its effects on the kidneys and blood pressure.
In patients with renal impairment, the initial dose of tacrolimus should be at the lower end of the range. If kidney function worsens during treatment (indicated by a rising creatinine), the doctor may need to reduce the dose or temporarily hold the medication. Tacrolimus is not removed by hemodialysis or peritoneal dialysis.
For patients with severe hepatic impairment (Child-Pugh score >10), the initial dose must be reduced significantly, often by 50% or more. These patients require very frequent blood level monitoring because the drug can stay in their system for a much longer time than usual.
> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring to ensure safety.
The primary effect of tacrolimus is the suppression of the cell-mediated immune response. The onset of immunosuppression is relatively rapid once therapeutic blood levels are reached, but the full effect on the immune system's 'memory' takes longer. There is a direct relationship between the 'trough' blood concentration (the lowest level before the next dose) and both the prevention of rejection and the risk of toxicity.
| Parameter | Value |
|---|---|
| Bioavailability | 5% to 67% (Average ~25%) |
| Protein Binding | ~99% (Albumin and Alpha-1-acid glycoprotein) |
| Half-life | 12 to 21 hours (highly variable) |
| Tmax (Time to peak) | 0.5 to 2 hours (Oral) |
| Metabolism | Hepatic (CYP3A4 and CYP3A5) |
| Excretion | Fecal (>92%), Renal (<1%) |
Tacrolimus is classified as a Calcineurin Inhibitor (CNI). It is therapeutically categorized as an immunosuppressant. It is more potent than cyclosporine (the first CNI discovered) and has largely replaced it in most transplant protocols due to a slightly better side-effect profile regarding gum hyperplasia and hair growth, though it carries a higher risk of diabetes.